Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Solving the Mysteries of Regeneration

Published: Thursday, August 22, 2013
Last Updated: Thursday, August 22, 2013
Bookmark and Share
Biologist Peter Reddien seeks to understand planarians’ famous ability to grow new body parts.

Few animals can rival the amazing regeneration abilities of the flatworms known as planarians: When the worms’ tails or heads are cut off, they grow new ones, and even a tiny piece of planarian tissue can regrow an entire animal.

Scientists first observed these phenomena more than a century ago, but until the past few years, they knew very little about how planarians achieve these incredible feats. MIT associate professor of biology Peter Reddien has made it his mission to discover the genetic and molecular basis of planarian regeneration, which he describes as one of the great mysteries of biology.

“Cellular and molecular insight into regeneration has come far in the past decade, but we’ve still got a long way to go to understand how an animal regrows a missing body part,” says Reddien, who is a core member of MIT’s Whitehead Institute. “That is the obsessive focus of my lab — to try to understand how regeneration happens, with the conviction that generation of fundamental knowledge about regeneration works will be important for understanding biology broadly and also for generating ideas for therapeutic applications.”

In recent years, Reddien’s lab has identified dozens of genes involved in planarian regeneration. Many of these are related to human genes, and some are active in response to human injuries. “It’s my hope that our continued work will enhance our understanding of what makes some animals great at regeneration and others not as good,” he says.

‘A golden era’


Growing up in Dallas, Reddien was drawn not to planarians but to planets. He closely followed the exploits of NASA, especially the travels of the Voyager spacecraft, with Voyager 2 reaching Neptune and heading out of the solar system by the time Reddien was 15 years old. “From a young age I thought I would be a physicist who would work for NASA or the Jet Propulsion Laboratory,” he says.

He entered the University of Texas as a physics major, but shifted gears after taking a required biology course.

“I realized that we were in a golden era for biological research, that this was going to be a period in history unlike any other for biological research … a period of great discoveries about how the fundamental attributes of life work,” Reddien recalls. “I found that exhilarating, and I got very excited about that as a future potential path for me.”

After graduating from college, Reddien came to MIT as a graduate student in molecular biology, working with Robert Horvitz, now the David H. Koch Professor of Biology. Among other projects, Horvitz’s lab was studying the molecular mechanisms of programmed cell death, a process critical to embryonic development and in defending against cancer.

Reddien finished his PhD in 2002 — the year Horvitz won the Nobel Prize in physiology or medicine for his work in programmed cell death — and went to the University of Utah to do postdoctoral research on regeneration. Reddien describes his decision at the time to launch into study of the molecular basis of regeneration in planarians as “a bit of a gamble.”

“There was a lot of potential, but it was off the radar and in its early stages as a molecular genetic field,” he says. “At that time, the tools for studying gene function in this organism were just in their infancy. There were no published roles for any gene at the time based on disrupting genes and studying what goes wrong in regeneration.”

At Utah, Reddien worked in the lab of Alejandro Sánchez Alvarado, who had recently shown that a new technique known as RNA interference, which allows genes to be selectively turned off, could work in planarians. Until that point, genetic studies of planarian regeneration had not been possible. Reddien was confident that new tools such as RNA interference could get planarians to reveal their regeneration secrets.

“No one had done it, and it was not an established system for taking that type of approach, so I did feel like I was taking a bit of a risk,” Reddien says. “It worked out better than I could have hoped, but I knew that the road was going to be full of challenges because there weren’t established paths to follow to study regeneration defects in these animals.”

A fundamental approach

Since joining the MIT faculty in 2005, Reddien has discovered dozens of genes that play key roles in regeneration, whether initiating the process or helping to determine which body part needs to be replaced. One gene that his lab investigated, known as notum, interacts with a cell-communication system called the Wnt signaling pathway to control whether an animal regrows a head or a tail.

Reddien also found that adult planarians maintain a population of pluripotent stem cells, known as clonogenic neoblasts, that can grow into any type of tissue. These cells are key to tissue regeneration, and his lab has identified genes that give these cells their regenerative potential.

“This is the kind of science you dream of when you’re a kid,” Reddien says. “We’re cutting off animals’ heads and figuring out how they regrow new ones at a molecular level. It’s up to us to develop the methods we need to solve these problems because it’s such a new field. It’s just been a real adventure and that’s something I’m greatly drawn to in science.”

Many of the genes that Reddien has discovered in planarians have counterparts in the human genome, though the functions of many in humans have been little studied. Learning more about them could help advance the field of regenerative medicine.

“We are taking a fundamental science approach to the problem, with the idea that evolution has already selected for mechanisms that allow regenerative repair events that would be the dream of regenerative medicine. The hope is that understanding these mechanisms could lead to new ideas about how applications could be derived to enhance wound healing and repair in humans,” Reddien says.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Wednesday, July 27, 2016
New Device can Study Electric Field Cancer Therapy
Microfluidic device allows study of electric field cancer therapy through low-intensity fields, preventing malignant cells spreading.
Friday, July 08, 2016
Long-Term Drug Release
New tablet attaches to the lining of the GI tract, resists being pulled away.
Thursday, April 07, 2016
Cancer Cells Remodel Environments Before Spreading
Researchers at MIT have found that the cancer cells remodel their environment to make it easier to reach nearby blood vessels.
Wednesday, March 16, 2016
Paving the Way for Metastasis
Cancer cells remodel their environment to make it easier to reach nearby blood vessels.
Tuesday, March 15, 2016
Curing Disease by Repairing Faulty Genes
New delivery method boosts efficiency of CRISPR genome-editing system.
Wednesday, February 03, 2016
No More Insulin Injections?
Encapsulated pancreatic cells offer possible new diabetes treatment.
Tuesday, January 26, 2016
Engineering Foe into Friend
Bose Grant awardee Jacquin Niles aims to repurpose the malaria parasite for drug delivery.
Monday, January 25, 2016
Supply Chain
Chemists discover how a single enzyme maintains a cell’s pool of DNA building blocks.
Wednesday, January 13, 2016
How Cancer Cells Spread
Study offers new targets for drugs that may prevent cancer from spreading.
Thursday, December 17, 2015
Delivering microRNAs for Cancer Treatment
Scientists exploit gene therapy to shrink tumors in mice with an aggressive form of breast cancer.
Wednesday, December 09, 2015
Using Ultrasound to Improve Drug Delivery
New approach could aid in treatment of inflammatory bowel disease.
Friday, October 23, 2015
Drug-Resistance Mechanism in Tumor Cells Unravelled
Targeting the RNA-binding protein that promotes resistance could lead to better cancer therapies.
Friday, October 23, 2015
Biologists Find Unexpected Role for Amyloid-Forming Protein
Yeast protein could offer clues to how Alzheimer’s plaques form in the brain.
Monday, September 28, 2015
Viruses Join Fight Against Harmful Bacteria
Engineered viruses could combat human disease and improve food safety.
Friday, September 25, 2015
Scientific News
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Testing Nanoparticle Drug Delivery in Dogs
Scientists have tested a nanoparticle drug delivery against bone cancer in dogs with promising results.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Exploiting Malaria’s Achilles’ Heel
Researchers have uncovered an Achilles' heel in malaria's anti-drug treatment arsenal that could lead to a disease cure.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!